Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04304001
Other study ID # FWA00005391
Secondary ID U54MD007582-34A1
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 7, 2021
Est. completion date February 29, 2024

Study information

Verified date May 2023
Source Florida A&M University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test the effectiveness of an outreach strategy to increase colorectal cancer (CRC) screening in African Americans. The investigators will recruit 250 African Americans ages 45-64 years who are not up-to-date with CRC screening or have never been screened, with the goal to evaluate screening knowledge, behavior, and intervention effects on CRC screening outcomes. Participants will be randomly assigned to the TUNE-UP intervention or a control group. The TUNE-UP intervention arm will utilize a community health advisor (CHA) to encourage return of stool blood testing kits through cell phone outreach. The control group will receive educational materials about CRC screening plus a resource list but no CHA counseling support or cellphone / text contact. The primary study outcome is receipt of CRC screening (colonoscopy or FIT) following the intervention. The secondary outcomes will include CRC screening knowledge, self-efficacy (confidence to receive CRC screening), intention to screen, and follow-up in the case of an abnormal test result. The research objective is to test the CHA intervention effectiveness for promoting stool blood testing as a preferred screening test in an under-screened African American population.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 115
Est. completion date February 29, 2024
Est. primary completion date February 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 64 Years
Eligibility Inclusion Criteria: 1. are 45 years to 64 years of age 2. self-identify as African American 3. have a working cellphone or telephone 4. are a resident of Florida 5. are non-adherent with CRC screening guidelines (i.e., no stool-based tests > 9 months, no colonoscopy within 9 years, and no flexible sigmoidoscopy within 4 years) 6. have no personal history of CRC cancer, precancerous colorectal polyps, or inflammatory bowel disease (ulcerative colitis or Crohn's disease). Exclusion Criteria: 1. under 45 years or over 64 years of age 2. do not self-identify as African American 3. do not have a working cellphone or telephone 4. not a resident of Florida 5. are adherent with CRC screening guidelines (i.e., stool-based tests < 9 months, colonoscopy within 9 years, and flexible sigmoidoscopy within 4 years) or 6. have a personal history of CRC cancer, precancerous colorectal polyps, or inflammatory bowel disease (ulcerative colitis or Crohn's disease).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Community Health Advisor
Intervention arm participants will receive one 45-minute face-to-face meeting followed by two CHA phone calls in one-week intervals over a period of three weeks beginning within one month following baseline survey completion. These CRC educational activities delivered by the CHAs will include the use of NCI CRC resources and materials, including an S2S PowerPoint presentation, and CRC educational brochures. The intervention will follow a conversation guide/standard script for intervention fidelity. CHAs will take notes following each interaction to document the call length, deviations from the script, and tone of the call. Participants will receive an additional text message reminder once a week for an additional three weeks - with instructions for participants to text "yes" to confirm they received the message - for a total of six weeks of intervention delivery. The personalized text messages will have positive tones and include short messages about the benefits of CRC screening.
Usual care
Control arm participants will receive a FIT kit, a mailed targeted colorectal cancer brochure, and complete a follow-up telephone survey at 3- and 12-months after the mailing.

Locations

Country Name City State
United States Florida A&M University Tallahassee Florida

Sponsors (2)

Lead Sponsor Collaborator
Florida A&M University National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of Colorectal Cancer Screening The colorectal cancer screening measure asks about completion of colonoscopy and blood stool tests. These tests are described prior to questions about completion of each test. The first question asks when was the most recent stool blood test (> 1 year but < 2 years ago; > 2 years but not more than 5 years ago; or > 5 years). The second question asks when was the most recent colonoscopy (a year ago or less; > 1 year but < 5 years ago; > 5 years but not more than 10 years ago; or > 10 years). Colorectal cancer screening receipt will be determined based on self-report and chart review to determine screening rates for each screening modality. Those answering a "a year ago or less" for the most recent stool blood test and "less than 10 years ago" for most recent colonoscopy are considered up to date. 12 months
Secondary Colorectal Cancer Screening Knowledge Scale Participants are asked four True/False questions about colon cancer: if their chance of getting colon cancer is higher if they have a family history, if it can be cured if caught early, if colon cancer is associated with pain or other symptoms, and if a warning sign of colon cancer is having a rash. They are also asked six additional True/False questions later in the survey to test knowledge about colorectal cancer screening. The range of the scale is 0-10. Each answer is scored as correct or incorrect. A score of 7 to 10 is considered "high". A score of 4 to 6 is considered "average". A score of 0 to 3 is considered "low." 12 months
Secondary Colorectal Cancer Screening Self-Efficacy Scale A validated 4-item measure of colorectal cancer screening self-efficacy (alpha = 0.82) asks participants to respond using a Likert scale about colorectal cancer screening test difficulty, finding time, ease of completing the test, and scheduling the test. Total scale scores range from 1 to 4. A score of 3 to 4 is considered "low self-efficacy" and a score of 1 to 2 is considered "high self-efficacy." 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05929820 - Impact of Protect Your Colon™ on CRC Screening N/A
Completed NCT02754661 - Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population. N/A
Completed NCT00955344 - Increasing Primary Care Physician Colorectal Cancer Screening Rates N/A
Completed NCT01141114 - Study of Patient Navigation to Promote Colon Cancer Screening N/A
Completed NCT01250015 - Does Numerical And Pictorial Information On Risk And Benefit Affects The Uptake Of Colorectal Cancer Screening? N/A
Completed NCT00503737 - Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates N/A
Completed NCT04746469 - Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits N/A
Completed NCT03208283 - Evaluation of the Impact of Water Method During Insertion Phase of Flexible Sigmoidoscopy in Training N/A
Not yet recruiting NCT03974542 - Telephone Outreach by Navigators to Improve Repeat Fecal Occult Blood Testing N/A
Completed NCT03176082 - Mailed Reminders Plus Fecal Immunochemical Testing N/A
Completed NCT01210235 - FLU-FIT Program at Kaiser Permanente Northern California N/A
Completed NCT00793455 - Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders N/A
Completed NCT01099826 - Increasing Colorectal Cancer (CRC) Screening In Primary Care N/A
Active, not recruiting NCT04631692 - Evaluating a Health Literacy Intervention to Improve Colorectal Cancer Screening in Underserved Areas N/A
Completed NCT03225560 - Smart Phone App for COLOnoscopic PREParation N/A
Completed NCT01054924 - Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening N/A
Completed NCT00148226 - ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial Phase 2
Completed NCT04131946 - Cancer Screening; Access; Awareness; Navigation N/A
Recruiting NCT05785780 - Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings N/A
Completed NCT04237883 - Primary Care Clinical Excellence Incentive Study N/A